Report on the First International Workshop on interim-PET scan in lymphoma
M. Meignan,
A. Gallamini,
C. Haioun
|
9 |
2009 |
9
2009
|
CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy.
R. Scheuermann,
E. Racila
|
8 |
1995 |
8
1995
|
Hyperleukocytic Leukemias and Leukostasis: A Review of Pathophysiology, Clinical Presentation and Management
7 auth.
P. Porcu,
L. Cripe,
E. Ng,
S. Bhatia,
Constance Danielson,
A. Orazi,
...
L. Mccarthy
|
8 |
2000 |
8
2000
|
Management of adverse events associated with idelalisib treatment: expert panel opinion
13 auth.
S. Coutre,
J. Barrientos,
Jennifer R. Brown,
S. de Vos,
R. Furman,
M. Keating,
Daniel Li,
S. O'brien,
J. Pagel,
M. Poleski,
...
J. Sharman,
N. Yao,
A. Zelenetz
|
8 |
2015 |
8
2015
|
Triptolide, A Novel Immunosuppressive and Anti-Inflammatory Agent Purified from a Chinese Herb Tripterygium Wilfordii Hook F
Benny J Chen
|
8 |
2001 |
8
2001
|
Granulocytic sarcoma: 32 cases and review of the literature
S. Paydaş,
S. Zorludemir,
M. Ergin
|
8 |
2006 |
8
2006
|
Indirubin and Meisoindigo in the Treatment of Chronic Myelogenous Leukemia in China
Zhijian Xiao,
Y. Hao,
Bing-cheng Liu,
L. Qian
|
8 |
2002 |
8
2002
|
Preclinical versus clinical drug combination studies
T. Chou
|
8 |
2008 |
8
2008
|
18-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CT
N. Mikhaeel,
A. Timothy,
M. O'Doherty,
S. Hain,
M. Maisey
|
8 |
2000 |
8
2000
|
Rituximab-related viral infections in lymphoma patients
7 auth.
S. Aksoy,
H. Harputluoglu,
S. Kılıçkap,
D. Dede,
O. Dizdar,
K. Altundağ,
...
I. Barista
|
7 |
2007 |
7
2007
|
Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib
O. Hantschel,
U. Rix,
G. Superti-Furga
|
7 |
2008 |
7
2008
|
Bone marrow-derived mesenchymal stem cells
K. Kemp,
J. Hows,
C. Donaldson
|
7 |
2005 |
7
2005
|
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
Yuan-Xiao Zhu,
K. M. Kortuem,
A. K. Stewart
|
7 |
2013 |
7
2013
|
Risk of Febrile Neutropenia among Patients with Intermediate-grade non-Hodgkin's Lymphoma Receiving CHOP Chemotherapy
G. Lyman,
V. Morrison,
D. Dale,
J. Crawford,
D. Delgado,
M. Fridman
|
7 |
2003 |
7
2003
|
Pathways and mechanisms of venetoclax resistance
P. Bose,
V. Gandhi,
M. Konopleva
|
7 |
2017 |
7
2017
|
Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance
9 auth.
V. Eleutherakis-Papaiakovou,
A. Bamias,
D. Gika,
A. Simeonidis,
A. Pouli,
A. Anagnostopoulos,
...
E. Michali,
T. Economopoulos,
K. Zervas
|
7 |
2007 |
7
2007
|
Improved Outcome of Zygomycosis in Patients with Hematological Diseases?
B. Gleissner,
A. Schilling,
I. Anagnostopolous,
I. Siehl,
E. Thiel
|
7 |
2004 |
7
2004
|
